CytoSorbents Reports First Quarter 2024 Results
May 09, 2024 16:17 ET
|
CytoSorbents
CytoSorbents Reports First Quarter 2024 Results
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO
May 09, 2024 12:00 ET
|
R3 Vascular
R3 Vascular, Inc. announced the closing of its $87 million Series B financing round and the appointment of a new President and Chief Executive Officer
Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring)
May 06, 2024 06:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
May 01, 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Vitestro Secures $22 Million (€20 million) for Autonomous Blood Draw Device
April 30, 2024 07:00 ET
|
Vitestro
Vitestro lands $22M to ramp up commercialization efforts for robotic blood draw device
Integer Holdings Corporation Reports First Quarter 2024 Results
April 25, 2024 08:00 ET
|
Integer Holdings Corporation
~ Strong start to the year with 1Q24 financial results ~~ Reiterate 2024 financial outlook ~ PLANO, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today...
Promising perspectives for the application of SDS Optic’s inPROBE technology platform for protein expression determination
April 25, 2024 08:00 ET
|
SDS Optic S.A.
SDS Optic's positive results from the Part I Clinical Trial of the novel optic fiber probe, inPROBE®, in vivo real-time molecular diagnostic technology.
Keiretsu Forum Regions Demonstrate Investment Stability Amidst Industry-Wide Downturns
April 23, 2024 07:29 ET
|
Keiretsu Forum Mid-Atlantic
In 2023, Keiretsu Forum MA-SE-TX region’s curated investment portfolio maintained a confident stance within an otherwise retreating investment ecosystem.
New Field Data Shows High Diagnostic Yield for Lung Biopsy Diagnosis Using the Galaxy System™
April 18, 2024 08:00 ET
|
Noah Medical
New Field Data Shows High Diagnostic Yield for Lung Biopsy Diagnosis Using the Galaxy System™
STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting
April 17, 2024 07:00 ET
|
CytoSorbents
STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting